Alexandria Real Estate Equities Inc (A6W.BE)
| Previous close | 110.10 |
| Open | 108.60 |
| Bid | 107.40 x 0 |
| Ask | 108.70 x 0 |
| Day's range | 108.60 - 108.60 |
| 52-week range | 86.98 - 122.45 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 22 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireAlexandria Real Estate Equities, Inc. Announces Long-Term 127,382 RSF Lease With Top 20 Pharmaceutical Company and Longstanding Credit Tenant for New R&D Life Science Center at the SD Tech by Alexandria Mega Campus in San Diego
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that a top 20 pharmaceutical company and longstanding credit tenant has increased its San Diego footprint by nearly 53% with the execution of a 10-year lease for 127,382 RSF, with significant expansion options, for a new R&D center at 10075 Barnes Canyon Road on the S
ZacksHere's Why You Should Retain Alexandria (ARE) Stock for Now
Alexandria (ARE) is likely to benefit from the solid demand for top-quality life science assets in key markets. However, a vast development outlay amid high interest rates is concerning.
ZacksAlexandria Real Estate Equities (ARE) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
